Publications by authors named "S Gouva"

Claim this Profile
F
First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study.
Karim Amrane, Margaux Geier, Romain Corre, Hervé Léna, Guillaume Léveiller, Sylvie Gouva

Cancer Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Evolution of the costs and management of lung cancer between 2004 and 2014].
F Gadby, R Descourt, G Robinet, G Quere, S Gouva

Rev Mal Respir· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis.
Elisabeth Gaye, Margaux Geier, Paul Bore, Marine Guilloïque, Francois Lucia, Sylvie Gouva

Lung Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma.
Karim Amrane, Delphine Le Goupil, Gilles Quere, Olivier Delcroix, Sylvie Gouva

Medicine (Baltimore)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas ().
J P Metges, M A Lebot, R Faroux, F Riaud, E Gamelin, S Gouva

Oncologie (Paris)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis